Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian CarcinomaRoberta Affatato, Giovanna Damia|Cancers|2020Cited by 38
Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor TreatmentRosaria Chilà, Giovanna Damia|Frontiers in Oncology|2022Cited by 8
BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft modelsFederica Guffanti, Giovanna Damia|Frontiers in Pharmacology|2024Cited by 3